What’s Behind $211,680 Sale at Vicor as AI Demand Surges
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesA tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
As mortgage costs ease slightly and new listings rise, starter home affordability crawling back is taking hold in sev...
The Global X Robotics & Artificial Intelligence ETF (BOTZ) is quietly tilting toward AI chips, with NVIDIA among its ...
IHS stock is up 57% as insiders trade. A CEO sale of 87,000 shares sparks questions about momentum and governance. Th...
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
Stratasys is stepping into 2025 with a focused plan to diversify revenue, improve margins, and scale software-led ser...
A surge of early arrivals has prompted airports to change guidance, arguing that arriving too early can slow lines fo...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...
When a company with a big run sees a director trim shares, investors naturally ask what comes next. This guide breaks...